Course series
Treatment of Menopause: Prescribe with Confidence, Backed by the Evidence
Set the record straight on hormone therapy and close the most overlooked treatment gap in midlife women's health: GSM.
What makes us different
Course Highlights
Untangle decades of hormone therapy (HT) confusion with the current evidence and The Menopause Society's 2022 Position Statement.
Close the GSM treatment gap: a chronic, progressive condition left untreated in the vast majority of women who have it.
Learn to identify optimal HT candidates using validated breast cancer and cardiovascular risk-assessment tools.
Walk away with evidence-based, culturally-informed language for starting HT and GSM conversations with patients.
Course Description
Learning objectives
After participating in this activity, learners will be able to:
Apply current evidence and clinical guideline recommendations to determine appropriate candidates for menopause hormone therapy through individualized risk-benefit assessment.
Evaluate hormonal and nonhormonal treatment options for menopause symptoms and genitourinary syndrome of menopause based on patient characteristics, preferences, and clinical presentation.
Incorporate evidence-based approaches to screening, diagnosis, monitoring, and long-term management of women receiving menopause treatment.
Utilize shared decision-making and patient-centered counseling to support informed treatment selection, improve symptom management, and optimize long-term health outcomes.
Overview
Curriculum
Module 1: Hormone Therapy: The Evidence Base
The WHI study in context, the current risk-benefit profile, and how dose, duration, route, and timing shape recommendations.
Module 2: Genitourinary Syndrome of Menopause (GSM)
The hypoestrogenic changes behind GSM, its symptom domains, and validated assessment tools.
Module 3: Identifying HT Candidates
Breast cancer and cardiovascular risk-assessment tools to guide prescribing decisions.
Module 4: Systemic vs. Localized Hormone Therapy
Mechanisms, delivery routes, and clinical indications for each approach.
Module 5: GSM Assessment & Treatment
A comprehensive GSM work-up, appropriate labs, and hormonal and non-hormonal treatment options.
Module 6: Patient Conversations
Starting evidence-based, culturally-informed conversations about HT and GSM.
meet the team
Faculty
Robin Noble, MD, MHCDS, MSCP
Chief Medical Officer
Board Certified OB/GYN; Certified Menopause Provider and Board Certified in Lifestyle Medicine
Chief Medical Advisor for Let's Talk Menopause
Laura Abrignani, NP, MSN, MSCP
Medical Affairs
Certified Menopause Provider & Owner, Coastal Well Woman Menopause Clinic
20+ Years in Medical Affairs with Evofem, Suneva, and Allergan
Michelle Nezolosky, MPH
Medical Writer
Former Director of Health Communications and Education at HerMD
10+ Years in Healthcare with Academic Research Experience at Dana-Farber Cancer Institute and Mt Sinai
Ready to prescribe with confidence?
Enroll now to see pricing and get started
Frequently asked questions
Who is this course for?
Clinicians who prescribe or want to prescribe hormone therapy, and any provider looking to better recognize and treat GSM.
Do I need to take the Foundations of Menopause program first?
No. Foundations of Menopause is not required before taking this course. If you are newer to menopause care, it provides helpful background on the physiology, symptoms, diagnosis, and foundational concepts that inform the prescribing considerations covered here.
If you already have a strong foundation in menopause care and want to focus specifically on hormone therapy and prescribing considerations, you can jump directly into this course.
How many CE credits will I earn?
3 CE credits.
How long do I have to complete the course?
This is an enduring, self-paced online activity. You will have up to 12 months from the date of purchase to complete the course.
Does this course cover both hormonal and non-hormonal options?
Yes, the course covers the evidence base for hormone therapy alongside non-hormonal GSM treatment options.
Is there an exam?
Yes. A knowledge assessment quiz with a minimum passing score of 80% is required to earn CE credit.
What if I don't pass the assessment?
You will have unlimited opportunities to retake the assessment until you achieve a passing score.
Additional Details
CME / CE Activity Detail Page
Treatment of Menopause - EncorVita™ Health
Activity Date: August 24, 2026 - August 24, 2029
Activity Type: Enduring
CE: 3 total credits
This activity offers 3 CE credit(s) for:
1. Physicians (AMA PRA Category 1 Credit™)
2. Nurses (ANCC NCPD)
3. Pharmacists (ACPE CPE)
4. Physician Assistants (AAPA Category 1)
5. Social Workers (ASWB-ACE)
6. Dietitians (CDR CPEUs)
7. Dentists (ADA-CERP CE)
8. Athletic Trainers (BOC CEUs)
9. Interprofessional Continuing Education (IPCE)
10. Other*
*All other attendees will receive an AMA PRA Category 1 Credit™ participation certificate
Instructions for Learning
This enduring educational activity consists of self-paced online modules designed to provide healthcare professionals with evidence-based education on the treatment of menopause, including hormone therapy and the diagnosis and management of genitourinary syndrome of menopause (GSM). Learners will progress through a structured curriculum that combines didactic instruction, interactive knowledge assessments, and clinical case-based learning to strengthen competence in individualized menopause management. Content is delivered through recorded educational modules, detailed PDF written material & tables, interactive learning activities, embedded quizzes, and clinical case scenarios. The self-paced format enables learners to complete the curriculum at their convenience while reinforcing knowledge through module-based assessments and clinical application exercises. To claim credit, participants must complete all required educational modules, complete the associated assessments, and submit the post-activity evaluation. Throughout the activity, learners will strengthen their ability to apply current evidence, individualize treatment decisions, and deliver patient-centered menopause care that improves symptom management, quality of life, and long-term health outcomes.
Statement of Need
Menopause affects millions of women each year, yet many healthcare professionals report limited confidence in evaluating candidates for hormone therapy and managing common menopause-related conditions such as genitourinary syndrome of menopause (GSM). Although substantial evidence has emerged over the past two decades, persistent misconceptions regarding the risks and benefits of hormone therapy—particularly following the 2002 Women's Health Initiative (WHI) publication—continue to influence clinical decision-making. Updated guidance from professional societies and evolving regulatory recommendations have clarified many of these issues, creating an ongoing need for education that reflects current evidence. Observable practice gaps include inappropriate avoidance of hormone therapy because of outdated risk perceptions, inconsistent cardiovascular and breast cancer risk assessment, limited familiarity with contemporary hormone formulations and routes of administration, inadequate screening for GSM, and underutilization of effective hormonal and nonhormonal treatment options. Because GSM symptoms are frequently underreported by patients and not routinely assessed by clinicians, many women experience persistent symptoms that negatively affect quality of life and sexual health.
Target Audience
This activity is suitable for Physicians, Nurses, Pharmacists, Physician Assistants, and other licensed healthcare professionals.
It is particularly relevant for physicians, nurse practitioners, physician assistants, registered nurses, pharmacists, and other licensed clinicians practicing in primary care, family medicine, internal medicine, obstetrics and gynecology, endocrinology, women's health, and related specialties who provide care for women during the menopause transition.
Disclosure Declaration
It is the policy of Pinnacle Conference, LLC, to ensure independence, balance, objectivity, scientific rigor, and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. Pinnacle Conference, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Faculty Disclosures
Robin Noble, MD, MHCDS, MSCP, has disclosed several financial relationships: Chief Medical Officer, Equity, and Consulting at EncorVita Health; Medical Advisor, Equity, and Consulting at Play Health; Chief Medical Advisor, Equity, and Consulting at Mia Health; Equity and Consultant at Indagare; Chief Medical Advisor at Let's Talk Menopause; Advisory Board and Equity at Bioceptive; Advisory Board and Equity at GYNtle; Advisory Board and Equity at Immugen; Advisory at DrKumo; Board Member and Shareholder Physician at Intermed, PA.
Laura Abrignani, NP, has disclosed several financial relationships: Speaker at Bayer Healthcare; Sr. Director, Medical Affairs at EncorVita Health.
Michelle Nezolosky, MPH, has disclosed several financial relationships: Independent Contractor at EncorVita Health; Independent Contractor at Eterna, Inc.; Employee at HerMD.
Laura Abrignani, NP, has disclosed several financial relationships: Speaker at Bayer Healthcare; Sr. Director, Medical Affairs at EncorVita Health.
Michelle Nezolosky, MPH, has disclosed several financial relationships: Independent Contractor at EncorVita Health; Independent Contractor at Eterna, Inc.; Employee at HerMD.
Planning Committee
Isabelle Raymond, PhD, has disclosed several financial relationships: Employee at Nutraceutical Wellness Inc; Advisor and Investor at EncorVita Health.
Corinne Erickson, MD, has disclosed several financial relationships: Speaker at Hydrinity; Speaker at Cartessa; Consultant/Advisor at L'Oreal; Advisor at EncorVita Health.
Chad Schiffman, MHA, has disclosed a financial relationship: Reviewer of course content on behalf of EncorVita Health (via Healthcare Compliance Pros).
Robin Noble, MD, MHCDS, MSCP, has disclosed several financial relationships: Chief Medical Officer, Equity, and Consulting at EncorVita Health; Medical Advisor, Equity, and Consulting at Play Health; Chief Medical Advisor, Equity, and Consulting at Mia Health; Equity and Consultant at Indagare; Chief Medical Advisor at Let's Talk Menopause; Advisory Board and Equity at Bioceptive; Advisory Board and Equity at GYNtle; Advisory Board and Equity at Immugen; Advisory at DrKumo; Board Member and Shareholder Physician at Intermed, PA.
Michelle Nezolosky, MPH, has disclosed several financial relationships: Independent Contractor at EncorVita Health; Independent Contractor at Eterna, Inc.; Employee at HerMD.
Laura Abrignani, NP, has disclosed several financial relationships: Speaker at Bayer Healthcare; Sr. Director, Medical Affairs at EncorVita Health.
Pamela Mehta, MD, has nothing to disclose.
Corinne Erickson, MD, has disclosed several financial relationships: Speaker at Hydrinity; Speaker at Cartessa; Consultant/Advisor at L'Oreal; Advisor at EncorVita Health.
Chad Schiffman, MHA, has disclosed a financial relationship: Reviewer of course content on behalf of EncorVita Health (via Healthcare Compliance Pros).
Robin Noble, MD, MHCDS, MSCP, has disclosed several financial relationships: Chief Medical Officer, Equity, and Consulting at EncorVita Health; Medical Advisor, Equity, and Consulting at Play Health; Chief Medical Advisor, Equity, and Consulting at Mia Health; Equity and Consultant at Indagare; Chief Medical Advisor at Let's Talk Menopause; Advisory Board and Equity at Bioceptive; Advisory Board and Equity at GYNtle; Advisory Board and Equity at Immugen; Advisory at DrKumo; Board Member and Shareholder Physician at Intermed, PA.
Michelle Nezolosky, MPH, has disclosed several financial relationships: Independent Contractor at EncorVita Health; Independent Contractor at Eterna, Inc.; Employee at HerMD.
Laura Abrignani, NP, has disclosed several financial relationships: Speaker at Bayer Healthcare; Sr. Director, Medical Affairs at EncorVita Health.
Pamela Mehta, MD, has nothing to disclose.
Content Reviewer
Shafqat Abbas, PharmD, has nothing to disclose.
All relevant financial relationships have been evaluated and mitigated.
Unlabelled Use Disclosure
Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. Pinnacle Conference, LLC, the faculty, planners, and EncorVita™ Health do not endorse the use of any product outside of the FDA-labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Credit Information
Jointly Accredited Provider
In support of improving patient care, this activity has been planned and implemented by EncorVita™ Health and Pinnacle Conference, LLC. Pinnacle Conference, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physicians - ACCME
Pinnacle Conference, LLC, designates this Enduring activity for a maximum of 3 AMA PRA Category 1 credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Note to Nurse Practitioners: Nurse practitioners can apply for AMA PRA Category 1 credits™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 credit™ from Jointly Accredited Organizations. Nurse practitioners can also apply for credit through their state boards.
Note to Nurse Practitioners: Nurse practitioners can apply for AMA PRA Category 1 credits™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 credit™ from Jointly Accredited Organizations. Nurse practitioners can also apply for credit through their state boards.
Nurses - ANCC
This activity is designated for 3 contact hours.
Pharmacists - ACPE
To receive CPE credit through CPE Monitor, please ensure you have provided your NABP ePID number and DOB appropriately. If you are unsure or would like to confirm, please contact ce@learnatpinnacle.com within 60 days of completing the activity.
Physicians Assistants - AAPA
Pinnacle Conference, LLC has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 3 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Athletic Trainers - BOC
Pinnacle Conference, LLC (BOC AP#: JA4008385) is approved by the Board of Certification, Inc. to provide continuing education to Athletic Trainers (ATs). This program is eligible for a maximum of (3) Category A hours/CEUs. ATs should claim only those hours actually spent in the educational program.
Registered Dietitians - CDR
Completion of this RD/DTR profession-specific or IPCE activity awards CPEUs (1 IPCE credits = 1 CPEU). If the activity is dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (1 hour/60 minutes = 1 CPEU). RDs and DTRs are to select activity type 102 in their Activity Logs. Performance Indicator selection is at the learner’s discretion.
Social Workers - ASWB
As a Jointly Accredited Organization, Pinnacle Conference, LLC is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 3 General continuing education credits.
Dentists - ADA-CERP CME
Pinnacle Conference, LLC is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP. Pinnacle Conference, LLC designates this activity for 3 hours continuing education credits. Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
(IPCE) Interprofessional Continuing Education Credit
This activity was planned by and for the healthcare team, and learners will receive 3 Interprofessional Continuing Education (IPCE) credits for learning and change.
